Open access · CC-BY
via OpenAlex
DNA methylation age acceleration is associated with risk of diabetes complications
Valentin Max Vetter, Johanne Spieker, Yasmine Sommerer, Nikolaus Buchmann, Christian Humberto Kalies, Vera Regitz‐Zagrosek, Lars Bertram, Ilja Demuth
Communications Medicine · 2023 · ▲ 43 citations
Abstract
Abstract Background Patients with Type 2 diabetes mellitus (T2D) are at risk for micro- and macrovascular complications. Implementable risk scores are needed to improve targeted prevention for patients that are particularly susceptible to complications. The epigenetic clock(definition) estimates an individual’s biological age using DNA methylation profiles. Methods In this study, we examined older adults of the Berlin Aging Study II that were reexamined on average 7.4 years after baseline assessment as part of the GendAge study. DNA methylation age (DNAmA) and its deviation from chronological age DNAmA acceleration (DNAmAA) were calculated with the 7-CpG clock (available at both timepoints, n = 1,071), Horvath’s clock, Hannum’s clock, PhenoAge and GrimAge (available at follow-up only, n = 1,067). T2D associated complications were assessed with the Diabetes Complications Severity Index (DCSI). Results We report on a statistically significant association between oral glucose tolerance test results and Hannum and PhenoAge DNAmAA. PhenoAge was also associated with fasting glucose. In contrast, we found no cross-sectional association after covariate adjustment between DNAmAA and a diagnosis of T2D. However, longitudinal analyses showed that every additional year of 7-CpG DNAmAA at baseline increased the odds for developing one or more additional complications or worsening of an already existing complication during the follow-up period by 11% in male participants with T2D. This association persisted after covariate adjustment (OR = 1.11, p = 0.045, n = 56). Conclusion Although our results remain to be independently validated, this study shows promising evidence of utility of the 7-CpG clock in identifying patients with diabetes who are at high risk for developing complications.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s43856-023-00250-8
- Canonical
- link ↗
- Fetched
- 2026-11-10 MST
Cite this
APA
Vetter, V.M., Spieker, J., Sommerer, Y., Buchmann, N., Kalies, C.H., Regitz‐Zagrosek, V., Bertram, L., & Demuth, I. (2023). DNA methylation age acceleration is associated with risk of diabetes complications. <em>Communications Medicine</em>. https://doi.org/10.1038/s43856-023-00250-8
Vancouver
Vetter VM, Spieker J, Sommerer Y, Buchmann N, Kalies CH, Regitz‐Zagrosek V, et al. DNA methylation age acceleration is associated with risk of diabetes complications. Communications Medicine. 2023. doi:10.1038/s43856-023-00250-8.
BibTeX
@article{valentin2023DNAmet,
title = {DNA methylation age acceleration is associated with risk of diabetes complications},
author = {Valentin Max Vetter and Johanne Spieker and Yasmine Sommerer and Nikolaus Buchmann and Christian Humberto Kalies and Vera Regitz‐Zagrosek and Lars Bertram and Ilja Demuth},
journal = {Communications Medicine},
year = {2023},
doi = {10.1038/s43856-023-00250-8},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
medRxiv 2022
Preprint · OA
DNA Methylation Age Acceleration, Type 2 Diabetes, and its Complications: Cross-sectional and Longitudinal Data from the Berlin Aging Study II (BASE-II)
Clinical Epigenetics 2026
Open access · CC-BY
Exploring a targeted epigenetic clock based on mortality-associated CpGs as a potential biomarker for frailty
Clinical epigenetics 2026
Open access · OA
Exploring a targeted epigenetic clock based on mortality-associated CpGs as a potential biomarker for frailty.
Aging and Disease 2025
Open access · CC-BY
Epigenetic Clocks Identify Harmful Epigenetic Aging Linked to Depression Severity and Cognitive Deficits in Major Depressive Disorder
Clinical Epigenetics 2016
Open access · CC-BY
Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort
Clinical Epigenetics 2026
Open access · CC-BY